{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Psarou EC"],"pubmed_abstract":["Chios mastic gum (CMG) exhibits several pharmacological activities that have been confirmed by numerous studies. These include antibacterial, anti-inflammatory, hypolipidemic, hypoglycemic, antiatheromatic, and benefits for against gastrointestinal disorders. However, studies focusing on CMG's safety are limited. The aim of the present study is to evaluate the genotoxicity of CMG using the limit test on the mammalian erythrocyte micronucleus assay, in male Wistar rats. CMG was administered by gavage to 5 rats at 2000 mg/kg bw for 3 days, while 5 rats received the vehicle and 5 rats received cyclophosphamide (positive control). Satellite groups of 3 rats were included for the negative control and CMG-treated groups to collect plasma and bone marrow for the chemical analyses. All rats were o"],"journal":["Toxicology reports"],"pagination":["102155"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12745950"],"repository":["biostudies-literature"],"pubmed_title":["<i>In vivo</i> genotoxicity of Chios mastic gum in rodent bone marrow micronucleus test."],"pmcid":["PMC12745950"],"pubmed_authors":["Meidanis M","Psarou EC","Anastasiadou P","Fokialakis N","Machera K","Kyriakopoulou K","Termentzi A"],"additional_accession":[]},"is_claimable":false,"name":"<i>In vivo</i> genotoxicity of Chios mastic gum in rodent bone marrow micronucleus test.","description":"Chios mastic gum (CMG) exhibits several pharmacological activities that have been confirmed by numerous studies. These include antibacterial, anti-inflammatory, hypolipidemic, hypoglycemic, antiatheromatic, and benefits for against gastrointestinal disorders. However, studies focusing on CMG's safety are limited. The aim of the present study is to evaluate the genotoxicity of CMG using the limit test on the mammalian erythrocyte micronucleus assay, in male Wistar rats. CMG was administered by gavage to 5 rats at 2000 mg/kg bw for 3 days, while 5 rats received the vehicle and 5 rats received cyclophosphamide (positive control). Satellite groups of 3 rats were included for the negative control and CMG-treated groups to collect plasma and bone marrow for the chemical analyses. All rats were o","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-06-06T09:36:03.525Z","creation":"2026-05-28T03:11:58.832Z"},"accession":"S-EPMC12745950","cross_references":{"pubmed":["41472790"],"doi":["10.1016/j.toxrep.2025.102155"]}}